Mucopolysaccharidosis (MPS) is an ultra-rare genetic disorder that affects every system in the human body. There are seven types of mucopolysaccharidosis presenting unique physical symptoms.
Babies with MPS appear normal at birth; symptoms become noticeable when they are around 1 or 2 years old. MPS is highly uncommon. It affects 1.57 per 100,000 live births.
While rare, learning about MPS can create awareness. Keep reading this article to understand what mucopolysaccharidosis (MPS) is, what causes it, and how it can be managed.
Mucopolysaccharidosis (MPS) is an inherited metabolic disorder. In people with MPS, a specific lysosomal enzyme required to break down glycosaminoglycans (GAGs), formerly mucopolysaccharides, does not work effectively. GAGs are complex sugar molecules essential in building connective tissues.
Since the sugar molecules don't break down completely, they accumulate in cells, tissues, and organs, causing progressive internal damage.
There are different types of MPS. Besides their distinct signs, the common symptoms include:
Besides these, affected people may also suffer from low intellect or intellectual disability. Some also show behavioral problems like depression, hyperactivity, or speech impairment.
MPS type | Name | Deficient Enzyme | Key Symptoms | Life expectancy |
MPS I | Hurler, Hurler-Scheie, Scheie syndrome (these are sub-categories) | Alpha-L-iduronidase | Coarse facial features, skeletal abnormalities, organ enlargement, respiratory and cardiac issues | Hurler: less than 10 years
Others: Normal lifespan |
MPS II | Hunter syndrome | Iduronate-2-sulfatase | Similar to MPS I, and visual & hearing loss | Severe form (neuronopathic): 10–20 years; Attenuated form: up to 50+ years. |
MPS III | Sanfilippo syndrome (four types A-D) | Mutations in specific genes respectively, causes deficiency of different types of enzymes in the 4 cases | Similar to MPS I, behavioral changes, sleep disorders, speech loss, intellectual impairment | Varied life expectancy, some live into their 20’s or 30’s |
MPS IV | Morquio syndrome (A and B) | A: N-acetylgalactosamine-6-sulfatase
B: Beta-galactosidase | Skeletal changes, dysplasia, hearing and vision loss, nerve compression | Less than 30 years |
MPS VI | Maroteaux-Lamy syndrome | N-acetylgalactosamine 4-sulfatase | Similar to MPS I, hearing and vision loss | 20-30 years |
MPS VII | Sly Syndrome | Beta-D-glucuronidase | Intellectual disability, hydrocephalus, joint stiffness, frequent pneumonia | 20 years |
MPS XI | Natowicz syndrome | Hyaluronidase | Soft tissue nodules near joints, facial changes, bone erosion | Not enough data (extremely rare) |
There is no cure for mucopolysaccharidosis (MPS). Regular monitoring and treatment can improve the lives of the patients. The treatments vary concerning the associated physical conditions.
Early diagnosis is crucial for managing MPS. Clinical evaluations, urine tests for GAGs, enzyme monitoring, and genetic testing are some ways to diagnose MPS.
Mucopolysaccharidosis is a rare and complex condition. MPS is an autosomal recessive condition; prevention is not possible. Early diagnosis, family support, and proper monitoring and treatment can improve lives.
People are becoming more aware of this rare condition. With researchers finding better treatments, the prospects of the people with MPS are looking up.
Also Read:
→ What is Hailey and Hailey Disease
→ What is a Dandy-Walker Malformation Associated With
→ What is the life expectancy of someone with HGPS
→ What Type of Disease is Bronchiectasis